Quarterly report pursuant to Section 13 or 15(d)

Note 8 - Accrued Liabilities

v3.22.2.2
Note 8 - Accrued Liabilities
9 Months Ended
Sep. 30, 2022
Notes to Financial Statements  
Accounts Payable and Accrued Liabilities Disclosure [Text Block]

8.

Accrued Liabilities

 

Accrued liabilities consisted of the following (in thousands):

 

   

September 30, 2022

   

December 31, 2021

 

Accrued compensation

  $ 303     $ 484  

Accrued clinical trial costs

    230       284  

Accrued research and other professional fees

    97       191  

Other

    7       7  

Total accrued liabilities

  $ 637     $ 966